Parallel Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.3K | Sell |
272
-12
| -4% | -$3.63K | ﹤0.01% | 1450 |
|
|
2025
Q1 | $94.1K | Buy |
284
+85
| +43% | +$28.2K | ﹤0.01% | 1297 |
|
|
2024
Q4 | $61.4K | Buy |
199
+111
| +126% | +$34.3K | ﹤0.01% | 1507 |
|
|
2024
Q3 | $18.7K | Hold |
88
| – | – | ﹤0.01% | 2121 |
|
|
2024
Q2 | $24.7K | Buy |
88
+5
| +6% | +$1.4K | ﹤0.01% | 1853 |
|
|
2024
Q1 | $22.2K | Hold |
83
| – | – | ﹤0.01% | 1921 |
|
|
2023
Q4 | $19.2K | Buy |
83
+78
| +1,560% | +$18K | ﹤0.01% | 1970 |
|
|
2023
Q3 | $730 | Hold |
5
| – | – | ﹤0.01% | 3032 |
|
|
2023
Q2 | $1.16K | Hold |
5
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q1 | $1.21K | Hold |
5
| – | – | ﹤0.01% | 2912 |
|
|
2022
Q4 | $1.45K | Buy |
+5
| New | +$1.45K | ﹤0.01% | 2798 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | – | – | 3204 |
|
|
2022
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 3147 |
|
|
2021
Q3 | – | Sell |
-2
| Closed | – | – | 3160 |
|
|
2021
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2989 |
|